Advanced Cellular Models for Preclinical Drug Testing: From 2D Cultures to Organ-on-a-Chip Technology
Cancer is a complex disease arising from a homeostatic imbalance of cell-intrinsic and microenvironment-related mechanisms. A multimodal approach to treat cancer that includes surgery, chemotherapy, and radiation therapy often fails in achieving tumor remission and produces unbearable side effects i...
Main Authors: | Valentina Foglizzo, Emiliano Cocco, Serena Marchiò |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-07-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/15/3692 |
Similar Items
-
Nanoparticles as Physically- and Biochemically-Tuned Drug Formulations for Cancers Therapy
by: Valentina Foglizzo, et al.
Published: (2022-05-01) -
Microfluidic Liver-on-a-Chip for Preclinical Drug Discovery
by: Jingyu Fu, et al.
Published: (2023-04-01) -
Recent advances in vascularized tumor-on-a-chip
by: Christina Bao Xian Huang, et al.
Published: (2023-03-01) -
Applications of Polymers for Organ-on-Chip Technology in Urology
by: Bianca Galateanu, et al.
Published: (2022-04-01) -
Bacteriophages as Therapeutic and Diagnostic Vehicles in Cancer
by: Valentina Foglizzo, et al.
Published: (2021-02-01)